Global Allergic Rhinitis Drugs Market Analysis and Forecast 2016-2020

Global Allergic Rhinitis Drugs Market Share, Trends, Size, Growth, Industry Analysis and Forecasts 2016-2020

Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.

Technavio's analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/global-allergic-rhinitis-drugs-market-2016-2020

Technavio's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors

AstraZeneca

GlaxoSmithKline

Table Of Content

PART 01: Executive summary

Highlights

Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/152434

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04:...